Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

doi:10.1084/jem.181.3.839

This Article

Full Text (PDF, 598K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Llorente, L.

Articles by Galanaud, P.

Search for Related Content

PubMed

PubMed Citation

Articles by Llorente, L.

Articles by Galanaud, P.

Pubmed/NCBI databases

Medline Plus Health Information
Substance via MeSH
Lupus

Social Bookmarking

What's this?

ARTICLES

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

L Llorente, W Zou, Y Levy, Y Richaud-Patin, J Wijdenes, J Alcocer-Varela, B Morel-Fourrier, JC Brouet, D Alarcon-Segovia and P Galanaud
Departamento de Immunologia y Reumatologia, Instituto Nacional de la Nutricion Salvador Zubiran, Mexico City D.F., Mexico.

Interleukin-10 (IL-10) is produced at a high level by B lymphocytes and monocytes of patients with systemic lupus erythematosus (SLE). In the present work, we analyzed whether this increased production of IL-10 contributed to the abnormal production of immunoglobulins (Ig) and of autoantibodies in SLE. The role of IL-10 was compared with that of IL- 6, another cytokine suspected to play a role in these abnormalities. The spontaneous in vitro production of IgM, IgG, and IgA by peripheral blood mononuclear cells from SLE patients was weakly increased by recombinant IL (rIL)-6, but strongly by rIL-10. This production was not significantly affected by an anti-IL-6 mAb but was decreased by an anti- IL-10 mAb. We then tested the in vivo effect of these antibodies in severe combined immunodeficiency mice injected with PBMC from SLE patients. The anti-IL-6 mAb did not significantly affect the serum concentration of total human IgG and of anti-double-stranded DNA IgG in the mice. In contrast, the anti-IL-10 mAb strongly inhibited the production of autoantibodies, and, to a lesser extent, that of total human IgG. These results indicate that the Ig production by SLE B lymphocytes is largely IL-10 dependent, and that the increased production of IL-10 by SLE B lymphocytes and monocytes may represent a critical mechanism in the emergence of the autoimmune manifestations of the disease.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Crispin, J. C., Tsokos, G. C. (2009). Human TCR-{alpha}{beta}+ CD4- CD8- T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype. J. Immunol. 183: 4675-4681 [Abstract] [Full Text]
De La Torre, M, Urra, J., Blanco, J (2009). Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?. Lupus 18: 216-222 [Abstract]
Heyneman, C. A. (2009). Systemic Lupus Erythematosus: A Therapeutic Update. Journal of Pharmacy Practice 22: 29-52 [Abstract]
Tamimoto, Y., Horiuchi, T., Tsukamoto, H., Otsuka, J., Mitoma, H., Kimoto, Y., Nakashima, H., Muta, K., Abe, Y., Kiyohara, C., Ueda, A., Nagasawa, K., Yoshizawa, S., Shimoda, T., Harada, M. (2008). A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines. Rheumatology (Oxford) 47: 821-827 [Abstract] [Full Text]
Chowdhary, V. R., Grande, J. P., Luthra, H. S., David, C. S. (2007). Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumatology (Oxford) 46: 1405-1410 [Abstract] [Full Text]
Kokeny, G., Godo, M., Nagy, E., Kardos, M., Kotsch, K., Casalis, P., Bodor, C., Rosivall, L., Volk, H-D., Zenclussen, A.C., Hamar, P. (2007). Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. Lupus 16: 465-477 [Abstract]
Langer, S., Langnickel, D., Enghard, P., Undeutsch, R., Burmester, G. R., Hiepe, F., Radbruch, A., Riemekasten, G. (2007). The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients. Rheumatology (Oxford) 46: 238-245 [Abstract] [Full Text]
Bobe, P., Bonardelle, D., Benihoud, K., Opolon, P., Chelbi-Alix, M. K. (2006). Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108: 3967-3975 [Abstract] [Full Text]
Ding, D., Mehta, H., McCune, W. J., Kaplan, M. J. (2006). Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus. J. Immunol. 177: 5878-5889 [Abstract] [Full Text]
Sanders, J-S F, Huitma, M G, Kallenberg, C G M, Stegeman, C A (2006). Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 65: 1484-1489 [Abstract] [Full Text]
Good, K. L., Bryant, V. L., Tangye, S. G. (2006). Kinetics of Human B Cell Behavior and Amplification of Proliferative Responses following Stimulation with IL-21. J. Immunol. 177: 5236-5247 [Abstract] [Full Text]
Astermark, J., Oldenburg, J., Pavlova, A., Berntorp, E., Lefvert, A.-K., for the MIBS Study Group, (2006). Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood 107: 3167-3172 [Abstract] [Full Text]
Sung, Y.-K., Park, B. L., Shin, H. D., Kim, L. H., Kim, S.-Y., Bae, S.-C. (2006). Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology (Oxford) 45: 400-404 [Abstract] [Full Text]
Baranda, L., de la Fuente, H., Layseca-Espinosa, E., Portales-Perez, D., Nino-Moreno, P., Valencia-Pacheco, G., Abud-Mendoza, C., Alcocer-Varela, J., Gonzalez-Amaro, R. (2005). IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology (Oxford) 44: 1507-1513 [Abstract] [Full Text]
Ripley, B J M, Goncalves, B, Isenberg, D A, Latchman, D S, Rahman, A (2005). Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis 64: 849-853 [Abstract] [Full Text]
Mathian, A., Weinberg, A., Gallegos, M., Banchereau, J., Koutouzov, S. (2005). IFN-{alpha} Induces Early Lethal Lupus in Preautoimmune (New Zealand Black x New Zealand White)F1 but Not in BALB/c Mice. J. Immunol. 174: 2499-2506 [Abstract] [Full Text]
Lauwerys, B R, Wakeland, E K (2005). Genetics of lupus nephritis. Lupus 14: 2-12 [Abstract]
Riemekasten, G., Langnickel, D., Enghard, P., Undeutsch, R., Humrich, J., Ebling, F. M., Hocher, B., Humaljoki, T., Neumayer, H., Burmester, G.-R., Hahn, B. H., Radbruch, A., Hiepe, F. (2004). Intravenous Injection of a D1 Protein of the Smith Proteins Postpones Murine Lupus and Induces Type 1 Regulatory T Cells. J. Immunol. 173: 5835-5842 [Abstract] [Full Text]
Schotte, H., Gaubitz, M., Willeke, P., Tidow, N., Assmann, G., Domschke, W., Schluter, B. (2004). Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response. Rheumatology (Oxford) 43: 1357-1363 [Abstract] [Full Text]
Houssiau, F. A. (2004). Management of Lupus Nephritis: An Update. J. Am. Soc. Nephrol. 15: 2694-2704 [Full Text]
Dorner, T, Lipsky, P E (2004). Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 13: 283-289 [Abstract]
Willeke, P, Schluter, B, Schotte, H, Erren, M, Mickholz, E, Domschke, W, Gaubitz, M (2004). Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption. Lupus 13: 257-262 [Abstract]
Ravirajan, C. T., Wang, Y., Matis, L. A., Papadaki, L., Griffiths, M. H., Latchman, D. S., Isenberg, D. A. (2004). Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody. Rheumatology (Oxford) 43: 442-447 [Abstract] [Full Text]
Asadullah, K., Sterry, W., Volk, H. D. (2003). Interleukin-10 Therapy--Review of a New Approach. Pharmacol. Rev. 55: 241-269 [Abstract] [Full Text]
Crispin, J C, Alcocer-Varela, J, de Pablo, P, Martinez, A, Richaud-Patin, Y, Alarcon-Segovia, D (2003). Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission. Lupus 12: 386-393 [Abstract]
Wang, C., Khalil, M., Ravetch, J., Diamond, B. (2003). The Naive B Cell Repertoire Predisposes to Antigen-Induced Systemic Lupus Erythematosus. J. Immunol. 170: 4826-4832 [Abstract] [Full Text]
Balabanian, K., Couderc, J., Bouchet-Delbos, L., Amara, A., Berrebi, D., Foussat, A., Baleux, F., Portier, A., Durand-Gasselin, I., Coffman, R. L., Galanaud, P., Peuchmaur, M., Emilie, D. (2003). Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus. J. Immunol. 170: 3392-3400 [Abstract] [Full Text]
Ronnelid, J, Tejde, A, Mathsson, L, Nilsson-Ekdahl, K, Nilsson, B (2003). Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an Fc{gamma}RII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 62: 37-42 [Abstract] [Full Text]
Yin, Z., Bahtiyar, G., Zhang, N., Liu, L., Zhu, P., Robert, M. E., McNiff, J., Madaio, M. P., Craft, J. (2002). IL-10 Regulates Murine Lupus. J. Immunol. 169: 2148-2155 [Abstract] [Full Text]
Gergely, P. Jr., Niland, B., Gonchoroff, N., Pullmann, R. Jr., Phillips, P. E., Perl, A. (2002). Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus. J. Immunol. 169: 1092-1101 [Abstract] [Full Text]
Grondal, G, Traustadottir, K H, Kristjansdottir, H, Lundberg, I, Klareskog, L, Erlendsson, K, Steinsson, K (2002). Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus 11: 435-442 [Abstract]
Lauwerys, B R, Van Snick, J, Houssiau, F A (2002). Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity. Lupus 11: 384-387 [Abstract]
Balabanian, K., Foussat, A., Bouchet-Delbos, L., Couderc, J., Krzysiek, R., Amara, A., Baleux, F., Portier, A., Galanaud, P., Emilie, D. (2002). Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood 99: 427-436 [Abstract] [Full Text]
Hase, K., Tani, K., Shimizu, T., Ohmoto, Y., Matsushima, K., Sone, S. (2001). Increased CCR4 expression in active systemic lupus erythematosus. J. Leukoc. Biol. 70: 749-755 [Abstract] [Full Text]
Blanco-Favela, F, Quintal, M. G, Chavez-Rueda, A K, Leanos-Miranda, A, Berron-Peres, R, Baca-Ruiz, V, Lavalle-Montalvo, C (2001). Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients. Lupus 10: 803-808 [Abstract]
Arce, E., Jackson, D. G., Gill, M. A., Bennett, L. B., Banchereau, J., Pascual, V. (2001). Increased Frequency of Pre-germinal Center B Cells and Plasma Cell Precursors in the Blood of Children with Systemic Lupus Erythematosus. J. Immunol. 167: 2361-2369 [Abstract] [Full Text]
Lopatin, U., Yao, X., Williams, R. K., Bleesing, J. J. H., Dale, J. K., Wong, D., Teruya-Feldstein, J., Fritz, S., Morrow, M. R., Fuss, I., Sneller, M. C., Raffeld, M., Fleisher, T. A., Puck, J. M., Strober, W., Jaffe, E. S., Straus, S. E. (2001). Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 97: 3161-3170 [Abstract] [Full Text]
Ostlie, N. S., Karachunski, P. I., Wang, W., Monfardini, C., Kronenberg, M., Conti-Fine, B. M. (2001). Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis. J. Immunol. 166: 4853-4862 [Abstract] [Full Text]
Gibson, A. W., Edberg, J. C., Wu, J., Westendorp, R. G. J., Huizinga, T. W. J., Kimberly, R. P. (2001). Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus. J. Immunol. 166: 3915-3922 [Abstract] [Full Text]
Strand, V (2001). Monoclonal antibodies and other biologic therapies. Lupus 10: 216-221 [Abstract]
Mishra, N., Brown, D. R., Olorenshaw, I. M., Kammer, G. M. (2001). Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc. Natl. Acad. Sci. USA 10.1073/pnas.051507098v1 [Abstract] [Full Text]
Bengtsson, A A, Sturfelt, G, Truedsson, L, Blomberg, J, Alm, G, Vallin, H, Ronnblom, L (2000). Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9: 664-671 [Abstract]
Balasa, B., Van Gunst, K., Jung, N., Balakrishna, D., Santamaria, P., Hanafusa, T., Itoh, N., Sarvetnick, N. (2000). Islet-Specific Expression of IL-10 Promotes Diabetes in Nonobese Diabetic Mice Independent of Fas, Perforin, TNF Receptor-1, and TNF Receptor-2 Molecules. J. Immunol. 165: 2841-2849 [Abstract] [Full Text]
Gunnarsson, I., Nordmark, B., Hassan Bakri, A., Grondal, G., Larsson, P., Forslid, J., Klareskog, L., Ringertz, B. (2000). Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment--the role of IL-10 and HLA. Rheumatology (Oxford) 39: 886-893 [Abstract] [Full Text]
Dean, G. S, Tyrrell-Price, J., Crawley, E., Isenberg, D. A (2000). Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59: 243-251 [Full Text]
Steinbach, F., Henke, F., Krause, B., Thiele, B., Burmester, G.-R., Hiepe, F. (2000). Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 59: 283-288 [Abstract] [Full Text]
Vallin, H., Perers, A., Alm, G. V., Ronnblom, L. (1999). Anti-Double-Stranded DNA Antibodies and Immunostimulatory Plasmid DNA in Combination Mimic the Endogenous IFN-{alpha} Inducer in Systemic Lupus Erythematosus. J. Immunol. 163: 6306-6313 [Abstract] [Full Text]
Nakashima, H., Akahoshi, M., Tanaka, Y., Yamaoka, K., Ogami, E., Nagano, S., Arinobu, Y., Niiro, H., Otsuka, T., Niho, Y. (1999). Polymorphisms within the interleukin-10 receptor cDNA gene (IL10R) in Japanese patients with systemic lupus erythematosus. Rheumatology (Oxford) 38: 1142-1144 [Abstract] [Full Text]
Schaefer, C. J, Lawrence, W D., Wooley, P. H (1999). Influence of long term silicone implantation on type II collagen induced arthritis in mice. Ann Rheum Dis 58: 503-509 [Abstract] [Full Text]
Rood, M J, Keijsers, V, van der Linden, M W, Tong, T Q T, Borggreve, S E, Verweij, C L, Breedveld, F C, Huizinga, T W J (1999). Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10�promoter haplotypes. Ann Rheum Dis 58: 85-89 [Abstract] [Full Text]
Kuroiwa, T, Lee, E G (1998). Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 7: 597-603 [Abstract]
Eskdale, J., Gallagher, G., Verweij, C. L., Keijsers, V., Westendorp, R. G.�J., Huizinga, T. W.�J. (1998). Interleukin 10�secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. USA 95: 9465-9470 [Abstract] [Full Text]
Mevorach, D., Zhou, J. L., Song, X., Elkon, K. B. (1998). Systemic Exposure to Irradiated Apoptotic Cells Induces Autoantibody Production. JEM 188: 387-392 [Abstract] [Full Text]
Lauwerys, B R, Houssiau, F A (1998). Cytokines: clues to the pathogenesis of SLE. Lupus 7: 211-213
Crispin, J C, Alcocer-Varela, J (1998). Interleukin-2 and systemic lupus erythematosus--fifteen years later. Lupus 7: 214-222 [Abstract]
Schwid, S. R., Goodman, A. D., Mattson, D. H. (1997). Autoimmune Hyperthyroidism in Patients With Multiple Sclerosis Treated With Interferon Beta-1b. Arch Neurol 54: 1169-1170 [Abstract]
Villarreal, G., Drenkard, C., Villa, A., Slor, H., Shafrir, S., Bakimer, R., Shoenfeld, Y., Alarcon-Segovia, D. (1997). Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity. Lupus 6: 425-435 [Abstract]
Houssiau, F., Lefebvre, C., Vanden Berghe, M., Lambert, M., Devogelaer, J-P., Renauld, J-C. (1995). Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4: 393-395 [Abstract]
Ma, W., Lim, W., Gee, K., Aucoin, S., Nandan, D., Kozlowski, M., Diaz-Mitoma, F., Kumar, A. (2001). The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages. J. Biol. Chem. 276: 13664-13674 [Abstract] [Full Text]
Mishra, N., Brown, D. R., Olorenshaw, I. M., Kammer, G. M. (2001). Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc. Natl. Acad. Sci. USA 98: 2628-2633 [Abstract] [Full Text]